Immune Evasion by Muscle-Specific Gene Expression in Dystrophic Muscle
Open Access
- 31 December 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (6) , 525-533
- https://doi.org/10.1006/mthe.2001.0496
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cross-Presentation, Dendritic Cells, Tolerance and ImmunityAnnual Review of Immunology, 2001
- An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and EpilepsyScience, 2000
- Targeting adenovirusGene Therapy, 2000
- Induction of Immunity to Antigens Expressed by Recombinant Adeno-Associated Virus Depends on the Route of AdministrationClinical Immunology, 1999
- Identification of a Kb-restricted CTL Epitope of β-Galactosidase: Potential Use in Development of Immunization Protocols for “Self” AntigensMethods, 1997
- Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.Journal of Clinical Investigation, 1997
- Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapyGene Therapy, 1997
- Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutationCell, 1995
- Neuromuscular transmission in the mdx mouseMuscle & Nerve, 1990
- INCREASED EXPRESSION OF HLA ABC CLASS I ANTIGENS BY MUSCLE FIBRES IN DUCHENNE MUSCULAR DYSTROPHY, INFLAMMATORY MYOPATHY, AND OTHER NEUROMUSCULAR DISORDERSThe Lancet, 1985